研究業績

研究業績2017年度 英文原著

詳細

 

1.英文原著

1. Nakahara K., Nakane S., Nakajima M., Yamashita S., Mori T., Ando Y. Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients. J Neuroimmunol 305:182-185, 2017.

 

2. Ishizaki M., Kedoin C., Ueyama H., Maeda Y., Yamashita S., Ando Y. Utility of skinfold thickness measurement in non-ambulatory patients with Duchenne muscular dystrophy. Neuromuscul Disord 27: 24-28, 2017.

 

 

3. Yamamoto F., Yamashita S., Kawano H., Tanigawa T., Mihara Y., Gonoi T., Ando Y. Meningitis and ventriculitis due to Nocardia araoensis infection. Intern Med 56: 853-859, 2017.

 

 

4. Tawara N., Yamashita S., Zhang X., Korogi M., Zhang Z., Doki T., Matsuo Y., Nakane S., Maeda Y., Sugie K., Suzuki N., Aoki M., Ando Y. Pathomechanisms of anti-cN1A autoantibodies in sporadic inclusion body myositis. Ann Neurol 81: 512-525, 2017.

 

 

5. Ikenoshita S., Yamashita S., Sakamoto T., Misumi Y., Ando Y. Hemi-atrophy of tongue with contralateral hemiparesis in a patient with MADSAM. J Clin Neurol 13: 422-423, 2017.

 

 

6. Yamashita S., Tawara N., Ando Y. Anti-NT5C1A autoantibodies for the diagnosis and study of the pathogenesis of sporadic inclusion body myositis. Clin Exp Neuroimmunol 8: 292-301, 2017.

 

 

7. Nagao Y., Nakajima M., Hirahara T., Wada K., Terasaki T., Nagamine M., Ando Y. Calcified cerebral embolism due to a calcified amorphous tumor. J Stroke Cerebrovasc Dis, 2018 in press.

 

 

8. Yamashita S., Nakama T., Ueda M., Honda S., Kimura E., Konagaya M., Ando Y. Tongue strength in patients with subacute myelo-optico-neuropathy. J Clin Neurosci 47: 84-88, 2018.

 

 

9. Inoue Y, Ueda M, Tasaki M, Takeshima A, Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, Matsumoto S, Yamashita T, Takahashi H, Kakita A, Ando Y. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy. Acta Neuropathol, 2017; 134: 605-617.

 

 

10. Inoue Y, Miyashita F, Koga M, Minematsu K, Toyoda K. Unclear-onset intracerebral hemorrhage: Clinical characteristics, hematoma features, and outcomes. Int J stroke 2017; 12: 961-968.

 

 

11. Inoue Y, Miyashita F, Minematsu K, Toyoda K. Clinical characteristics and outcomes of intracerebral hemorrhage in very elderly. J Stroke Cerebrovasc Dis 2018, 27: 97-102.

 

 

12. Ikeda T, Masuda T, Ueda M, Yamashita T, Misumi Y, Shinriki S, Ando Y: Unwanted road to anemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment. Ann Clin Biochem. Jan 1, 2018

 

 

13. Yamashita T, Ueda M, Misumi Y, Masuda T, Nomura T, Tasaki M, Takamatsu K, Sasada K, Obayashi K, Matsui H, Ando Y: Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. J Neurol 265: 134-140, 2018

 

 

14. Okada M, Misumi Y, Ueda M, Yamashita T, Masuda T, Tasaki M, Ando Y: A novel transthyretin variant V28S (p.V48S) with a double-nucleotide substitution in the same codon. Amyloid 24: 231-232, 2017

 

 

15. Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y: Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy. Neurology 88: 2192-2197, 2017

 

 

16. Suenaga G, Ikeda T, Masuda T, Motokawa H, Yamashita T, Takamatsu K, Misumi Y, Ueda M, Matsui H, Senju S, Ando Y: Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin. Sci Rep 7: 1579, 2017

 

 

17. Matsumoto S, Ueda M, Yamashita T, Amano T, Misumi Y, Tasaki M, Masuda T, Mizukami M, Furuya H, Ando Y: A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation. Amyloid 24: 97-98, 2017

 

 

18. Tasaki M, Ueda M, Obayashi K, Kinoshita Y, Matsumoto S, Mizukami M, Masuda T, Misumi Y, Yamashita T, Ando Y: Identification of amyloid precursor protein from autopsy and biopsy specimens using LMD-LC-MS/MS: the experience at Kumamoto University. Amyloid 24: 167-168, 2017

 

 

19. Izaki A, Obayashi K, Suenaga G, Ueda M, Yamashita T, Tasaki M, Yanagisawa Y, Masuda T, Misumi Y, Ando Y: In vitro and in vivo assessment of novel derivatives for detecting various amyloid deposits. Amyloid 24: 17, 2017

20. Nomura T, Yamashita T, Misumi Y, Ueda M, Masuda T, Tasaki M, Ando Y: A case with a novel variant transthyretin A36D presenting cardiac phenotype. Amyloid 24: 100, 2017

 

 

21. Tsuda Y, Misumi Y, Ueda M, Tasaki M, Huang G, Masuda T, Suenaga G, Kinoshita Y, Obayashi K, Yamashita T, Ando Y: Iatrogenic systemic transthyretin amyloid deposits in a case with domino liver transplantation: an autopsy case study. Amyloid 24: 125, 2017

 

 

22. Obayashi K, Ueda M, Yamashita T, Tasaki M, Izaki A, Yanagisawa Y, Masuda T, Misumi Y, Ando Y: Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (ATTR) V30M hereditary amyloidosis with polyneuropathy (FAP). Amyloid 24: 99, 2017

 

 

23. Watanabe T, Obayashi K, Misumi Y, Tasaki M, Shinriki S, Ando T, Akagami T, Ueda M, Yamashita T, Hirotani S, Ando Y: Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg. Amyloid 24: 119, 2017

 

 

24. Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda SI, Katsuno M, Sobue G: Disruption of blood-nerve barriers in hereditary transthyretin (ATTR) amyloidosis. Amyloid 24: 89-90, 2017

 

 

25. Mizukami M, Ueda M, Tasaki M, Misumi Y, Masuda T, Matsumoto S, Yamashita T, Ando Y: Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study. Amyloid 24: 122, 2017

 

 

26. Misumi Y, Oshima T, Ueda M, Yamashita T, Tasaki M, Masuda T, Obayashi K, Ando Y: Occurrence factors and clinical picture of iatrogenic transthyretin amyloidosis after domino liver transplantation. Amyloid 24: 123-124, 2017

 

 

27. Yanagisawa Y, Obayashi K, Tasaki M, Izaki A, Masuda T, Misumi Y, Ueda M, Yamashita T, Ando Y: Clinicopathological characteristics of a patient with ureteral amyloidosis. Amyloid 24: 101, 2017

 

 

28. Yamashita T, Ueda M, Tasaki M, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Ando Y: Establishment of a diagnostic center for amyloidosis in Japan by Kumamoto University. Amyloid 24: 169-170, 2017

 

 

29. Misumi Y, Ueda M, Yamashita T, Masuda T, Kinoshita Y, Tasaki M, Nagase T, Ando Y: Novel screening for transthyretin amyloidosis by using fat ultrasonography. Ann Neurol. 81: 604-608, 2017

 

 

30. Huang G, Ueda M, Tasaki M, Yamashita T, Misumi Y, Masuda T, Suenaga G, Inoue Y, Kinoshita Y, Matsumoto S, Mizukami M, Tsuda Y, Nomura T, Obayashi K, Ando Y. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation. Amyloid, 2017;24:24-29.

 

 

31. Oda S, Utsunomiya D, Nakaura T, Yuki H, Kidoh M, Morita K, Takashio D, Yamamuro M, Izumiya Y, Hirakawa K, Ishida T, Tsujita K, Ueda M, Yamashita T, Ando Y, Hata H, Yamashita Y. Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging. Circ J, 2017;81:1014-1021.

 

 

32. Oda S, Utsunomiya D, Nakaura T, Morita K, Komi M, Yuki H, Kidoh M, Hirata K, Funama Y, Yamamuro M, Ogawa H, Ueda M, Yamashita T, Ando Y, Yamashita Y. Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy. Eur Radiol, 2017 (in press)

 

 

33. Nagatoshi A, Ueda M, Ueda A, Tasaki M, Inoue Y, Ma M, Masuda T, Mizukami M, Matsumoto S, Kosaka T, Kawano T, Ito T, Ando Y. Serum amyloid P component: a novel potential player in vessel degeneration in CADASIL. J Neurol Sci, 2017;379:69-76.

34. Nishi S, Hoshino J, Yamamoto S, Fuji H, Goto S, Ubara Y, Motomiya Y, Morita H, Takaichi K, Yamagata K, Shigematsu T, Ueda M, Ando Y. A multicenter cross sectional study for dialysis related amyloidosis in Japan. Nephrology, 2017 (in press)

 

 

35. Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, Ueda M, Yamashita T, Ishibashi-Ueda H, Yasuda S, Ogawa H, Ando Y, Anzai T, Tsujita K. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis. ESC Heart Fail, 2018;5:27-35.

 

 

36. Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekishima Y, Ikeda S, Yazaki M, Fukushima W, Ando Y. Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan. Intern Med. 2018;57:181-187.

 

 

37. Sekijima, Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y. First Nationwide Survey on Wild-type ATTR Amyloidosis in Japan. Amyloid, 2017 (in press)

 

 

38. Shinriki S, Jono H, Maeshiro M, Nakamura T, Guo J, Li JD, Ueda M, Yoshida R, Shinohara M, Nakayama H, Matsui H, Ando Y. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma. J Pathol, 2018;244:367-379.

 

 

39. Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y: Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy. Neurology, 88: 2192-2197, 2017

 

 

40. Watari M, Nakane S, Mukaino A, Nakajima M, Mori Y, Maeda Y, Masuda T, Takamatsu K, Kouzaki Y, Higuchi O, Matsuo H, Ando Y. Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol. 2017 in press.

 

 

41. Nakane S, Ando Y, Matsuo H. Yips preceding baseball-related dystonia. Parkinsonism Relat Disord. 2018 in press.

 

 

42. Ichinose K, Ohyama K, Furukawa K, Higuchi O, Mukaino A, Satoh K, Nakane S, Shimizu T, Umeda M, Fukui S, Nishino A, Nakajima H, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yoshida M, Kuroda N, Kawakami A. Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus. Clin Immunol. 2017 in press.

 

 

43. Nakae Y, Hyuga M, Kishimoto W, Fukunaga A, Tabata S, Maesako Y, Arima N, Terada Y, Komatsu K, Higuchi O, Nakane S, Arima T. Multiple myeloma presenting with autoimmune autonomic ganglionathy. Intern Med. 2017;56:3347-51.

 

 

44. Ishikawa H, Taniguchi A, Ii Y, Higuchi O, Matsuo H, Nakane S, Asahi M, Niwa A, Tomimoto H. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive lymphoma. Neuromuscul Disord. 2017;27:914-7.

 

 

45. Nakane S, Furutani K, Harada M, Urushihara R, Matsui N, Izumi Y, Kaji R. Multimodal analysis based on high-field magnetic resonance and motor evoked potentials. Clin Exp Neuroimmunol. 2017;8:43-46.

 

 

46. Yoshifuku A, Yoneda K, Sakiyama Y, Higuchi O, Nakane S, Kanekura T. Case of autoimmune autonomic ganglionopathy manifesting anhidrosis. J Dermatol. 2017;44:1160-1163.

 

 

47. Morimoto N, Takahashi S, Inaba T, Takamiya M, Kageyama Y, Morimoto M, Takahashi Y, Nishimura H, Nakane S, Abe K. A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm. J Clin Neurosci. 2017;39:90-2.

 

 

48. Sakai W, Nakane S*, Urasaki E, Nagaishi A, Toyoda K, Sadakata E, Fukudome T, Yamakawa Y, Matsuo H. The cross-sectional area of paraspinal muscles predicts the efficacy of deep brain stimulation for camptocormia. J Parkinsons Dis. 2017;7:247-253.

 

 

49. Nakane S*, Mukaino A, Maeda Y, Higuchi O, Matsuo H, Ando Y. Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey. J Neurol Neurosurg Psychiatry. 2017;88:367-8.

 

 

50. Naganuma M, Inatomi Y, Nakajima M, Takeshi Ohta, Yonehara T, Ando Y: Is the occlusion site of the lenticulostriate artery identified on admission related to clinical prognosis in patients with lacunar stroke? J Stroke Cerebrovasc Dis, in press.

 

 

51. Naganuma M, Inatomi Y, Nakajima M, Yonehara T, Ando Y: The association between uric acid level and 3-month functional outcome in acute ischemic stroke patients treated with/without edaravone. Cerebrovasc Dis, in press.

 

 

52. Miura M, Nakajima M, Fujimoto A, Shiraishi S, Liebeskind DS, Ando Y. Decreased signal intensity ratio on MRA reflects misery perfusion on SPECT in patients with intracranial stenosis. J Neuroimaging 28:206-211.

 

 

53. Miura M, Nakajima M, Fujimoto A, Kaku Y, Kawano T, Watanabe M, Kuratsu J, Ando Y. High prevalence of small vessel disease long after cranial irradiation. J Clin Neurosci 2017;46:129-135.)

 

 

54. Tsukamoto H, Fujieda K, Senju S, Ikeda T, Oshiumi H, Nishimura Y: Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity. Cancer Sci Mar; 109 (3): 523-530, 2018

 

 

55. Ikeda T: Stratified analyses are necessary to verify the influence of salt intake in MS. Ann Neurol Oct; 82(4): 648-649, 2017

 

 

56. Maeda Y, Yonemochi Y, Nakajyo Y, Hidaka H, Ikeda T, Ando Y: CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration. Sci Rep Jun 12; 7 (1): 3305, 2017

 

 

57. Nishi S., Muso E., Shimizu A., Sugiyama H., Yokoyama H., Ando Y., Goto S., Fujii H.: A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study. Clin Exp Nephrol, 21, 624-632 , 2017

 

 

58. Kasagi T., Nobata H., Suzuki K., Miura N., Banno S., Takami A., Yamashita T., Ando Y., Imai H.: Light chain deposition disease diagnosed with laser micro-dissection, liquid chromatography, and tandem mass spectrometry of nodular glomerular lesions. Intern Med, 56, 61-66 , 2017

 

 

59. Inatomi Y., Nakajima M., Yonehara T., Ando Y.: Ipsilateral tremor-like grasp reaction in a patient with ischemic stroke. Cogn Behav Neurol, 30, 37-41, 2017

 

 

60. Singu T., Inatomi Y., Yonehara T., Ando Y. : Calcified amorphous tumor causing shower embolism to the brain: A case report with serial echocardiographic and neuroradiologic images and a review of the literature. J Stroke Cerebrovasc Dis, 26, e85-e89, 2017

 

 

61. Inatomi Y., Nakajima M., Yonehara T., Ando Y.: Clinical characteristics of patients seizure following the 2016 Kumamoto earthquake.: J Clin Neurosci, 40, 123-129 ,2017

 

 

62. Hayashi Y., Higashi T., Motoyama K., Jono H., Ando Y., Arima H.
In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran. Int J Biol Macromol, 107, 1113-1121 , 2018

 

 

63. Fukasawa K., Higashimoto Y., Ando Y., Motomiya Y. Selection of DNA aptamer that blocks the fibrillogenesis of a proteolytic amyloidogenic fragment of β2 m. Ther Apher Dial, 22, 61-66 , 2018

 

 

64. Inatomi Y., Nakajima M., Yonehara T., Ando Y.

Clinical characteristics of patients with ischemic stroke following the 2016 Kumamoto earthquake. J Clin Neurosci, 46, 79-84, 2018

 

 

65. Ikenoshita S., Yamashita S., Sakamoto T., Misumi Y., Ando Y.

Hemiatrophy of the tongue with contralateral hemiparesis in a patient with multifocal acquired demyelinating sensory and motor neuropathy. J Clin Neurol, 13, 422-423 , 2017

 

 

66. Singu T., Inatomi Y., Yonehara T., Ando Y Delayed leukoencephalopathy after recanalized cardioembolic stroke: Two case reports. J Neurol Sci, 379, 81-83, 2017

 

 

67. Nishi S., Hoshino J., Yamamoto S., Goto S., Fuji H., Ubara Y., Motomiya Y., Morita H., Takaichi K., Yamagata K., Shigematsu T., Ueda M., Ando Y. A multicenter cross sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan. Nephrology, 2017 in press

 

 

68. Ando Y., Ueda M.
Antibody therapy for transthyretin-related hereditary amyloid polyneuropathy: another therapeutic option.
Amyloid, 24, 113-114 ,2017

 

 

69. Tsuda N., Shiraishi S., Oda S., Ogasawara K., Sakamoto F., Tomiguchi S., Fujisue K., Takashio S., Izumiya Y., Tsujita K., Ando Y., Yamashita Y.

Utility of single-photon emission computed tomography/computed tomography fusion imaging with 99 mTc-Pyrophosphate scintigraphy in the assessment of cardiac transthyretin amyloidosis.Circ J. 2017 in press

 

 

70. Oda S., Nakaura T., Utsunomiya D., Hirakawa K., Takashio S., Izumiya Y., Tsujita K., Hata H.,

Ando Y., Yamashita Y.

Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner.
Amyloid, 1-2 ,2018

 

 

71. Ikeda T., Masuda T., Ueda M., Yamashita T., Misumi Y., Shinriki S., Ando Y.

Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.

Ann Clin Biochem, 2018 in press

 

 

72. Mukaino A, Nagaoka A, Yoshimura S, Nakajima H Shiraishi H, Motomura M, Morikawa M, Kusunoki S, Nakane S, Ando Y, Tsujino A.

Modified method of intravenous immunoglobulin administration for patients with intractable multifocal motor neuropathy: A case report., Clinical and Experimental Neuroimmunology , 2: 141-145, 2017

Copyright© Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.